Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Abbott Laboratories(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Boston Scientific(MODEST), BIOSENSORS(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(MODEST), Daiichi Sankyo(MODEST), philips/volcano(SIGNIFICANT), Siemens(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), PHILIPS/Spectranetics/Volcano(SIGNIFICANT), Merck & Co., Inc.(MODEST), Sanofi Aventis(SIGNIFICANT), Medtelligence (Janssen)(MODEST), Roivant Sciences(MODEST) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), CSL Behring (SIGNIFICANT), DSI(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Medtronic(SIGNIFICANT), OrbusNeich(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Elixir Medical(MODEST), CONTROLRAD(MODEST), medtronic(SIGNIFICANT), Claret Medical(MODEST), PLx Opco/PLx Pharma(MODEST)

View Full Disclosure